We are live on ! Find out more
Mitsubishi UFJ Asset Management

Mitsubishi UFJ Asset Management Portfolio holdings

AUM $180B
1-Year Est. Return 37.51%
This Fund
S&P 500
This Quarter Est. Return
+14.84%
1 Year Est. Return
+37.51%
3 Year Est. Return
+115.4%
5 Year Est. Return
+142.39%
10 Year Est. Return
+552.78%
AUM
$12.9B
AUM Growth
+$2.06B
Cap. Flow
+$696M
Cap. Flow %
5.38%
Top 10 Hldgs %
21.98%
Holding
1,047
New
43
Increased
776
Reduced
154
Closed
22

Sector Composition

Rank Sector Weight
1 Technology 23.27%
2 Consumer Discretionary 12.53%
3 Healthcare 12.45%
4 Financials 11.19%
5 Communication Services 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GILT icon
951
Gilat Satellite Networks
GILT
$846M
$206K ﹤0.01%
31,543
+17,407
+123% +$101K
QURE icon
952
uniQure
QURE
$3.12B
$205K ﹤0.01%
5,662
+2,591
+84% +$109K
GOOD
953
Gladstone Commercial Corp
GOOD
$619M
$203K ﹤0.01%
11,296
+195
+2% +$3.44K
DOYU
954
DouYu International Holdings
DOYU
$139M
$202K ﹤0.01%
+1,830
New +$248K
CNMD icon
955
CONMED
CNMD
$1.48B
$199K ﹤0.01%
1,780
-227
-11% -$21.5K
INO icon
956
Inovio Pharmaceuticals
INO
$79.1M
$194K ﹤0.01%
1,827
+719
+65% +$95.7K
QTWO icon
957
Q2 Holdings
QTWO
$3.95B
$194K ﹤0.01%
1,535
+153
+11% +$16.5K
UMH
958
UMH Properties
UMH
$1.38B
$194K ﹤0.01%
13,089
-231
-2% -$3.36K
ALX
959
Alexander's
ALX
$1.39B
$191K ﹤0.01%
688
NVS icon
960
Novartis
NVS
$294B
$190K ﹤0.01%
2,007
+314
+19% +$27.4K
HQY icon
961
HealthEquity
HQY
$8.83B
$187K ﹤0.01%
2,676
+767
+40% +$47.7K
TECX
962
Tectonic Therapeutic
TECX
$623M
$185K ﹤0.01%
1,107
+72
+7% +$12.8K
SAP icon
963
SAP
SAP
$242B
$184K ﹤0.01%
1,414
+554
+64% +$71.5K
BPYU
964
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
$183K ﹤0.01%
12,216
-3,854
-24% -$58.6K
SRG
965
Seritage Growth Properties
SRG
$135M
$182K ﹤0.01%
12,422
+2,262
+22% +$33.4K
TECH icon
966
Bio-Techne
TECH
$11.2B
$182K ﹤0.01%
2,288
+192
+9% +$13.9K
FLXN
967
DELISTED
Flexion Therapeutics, Inc.
FLXN
$180K ﹤0.01%
+15,636
New +$182K
XRN
968
Chiron Real Estate Inc
XRN
$465M
$176K ﹤0.01%
2,694
GRFS
969
Grifois
GRFS
$5.44B
$175K ﹤0.01%
9,487
+2,294
+32% +$42.5K
IIIV icon
970
i3 Verticals
IIIV
$331M
$169K ﹤0.01%
5,078
+2,267
+81% +$60.8K
BSBR icon
971
Santander
BSBR
$43.1B
$168K ﹤0.01%
20,285
+438
+2% +$2.9K
INFY icon
972
Infosys
INFY
$51B
$168K ﹤0.01%
9,923
-8,212
-45% -$126K
EVOP
973
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
$168K ﹤0.01%
6,220
+1,432
+30% +$36K
SNY icon
974
Sanofi
SNY
$104B
$166K ﹤0.01%
3,408
+521
+18% +$25.7K
CYBE
975
DELISTED
Cyberoptics Corp
CYBE
$166K ﹤0.01%
7,320
+3,986
+120% +$113K

Similar funds

Mitsubishi UFJ Asset Management's Q4 2020 Portfolio in Review

As of Q4 2020, Mitsubishi UFJ Asset Management held 1,047 positions worth $12.9B, up 19% from $10.9B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Mitsubishi UFJ Asset Management deployed $696M of net new capital in Q4 2020, opening 43 new positions and adding to 776 existing holdings. Its largest new stake was Goosehead Insurance: 40,600 shares worth $5.07M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Amgen, an estimated $20.2M trimmed.

  • Mitsubishi UFJ Asset Management's largest Q4 2020 buy was Goosehead Insurance: 40,600 shares worth $5.07M.
  • Mitsubishi UFJ Asset Management added most to Tesla in Q4 2020, an estimated $42.1M increase.
  • Mitsubishi UFJ Asset Management's biggest Q4 2020 reduction was Amgen, cutting an estimated $20.2M.
  • Mitsubishi UFJ Asset Management fully exited E*Trade Financial Corporation in Q4 2020, selling an estimated $2.31M.
  • Mitsubishi UFJ Asset Management's ten largest holdings make up 22% of its $12.9B portfolio in Q4 2020.
  • Mitsubishi UFJ Asset Management opened 43 new positions and closed 22 in Q4 2020.
  • Mitsubishi UFJ Asset Management's portfolio value rose 19% quarter-over-quarter to $12.9B.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q4 2020, filed 9 Feb 2021.